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Salmonella (MIGo ~0.0625) and Pantoea (~0.0625). 
Among the other organisms ertapenem inhibited 7/9 
strains of Acinetobacter at MIC 18 kg/ml, and O/3 strains 
of Stenotrophomonas at MIC 58 kg/ml. Thirteen of 
19 (68%) strains of Pseudomonas were susceptible to 
ertapenem - 2 strains MIC 1 &ml, 4 strains MIC 2 
kg/ml, 5 strains MIC 4 Fg/ml, 2 strains MIC 8 pg/ml and 
6 strains 116 kg/ml. Overall, ertapenem displayed good 
activity against common aerobic gram negative bacilli 
isolated from BSI in cancer patients. Thus ertapenem 
may be a potential candidate for the therapy of micro- 
biologically documented infections involving susceptible 
organisms in cancer patients. 
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Introduction: Although Candida and Aspergillus are the 
predominant fungal pathogens in immunocompromised 
patients, over the last decade there has been an increase 
in the number of pathogens recognized as causing 
invasive diseases in this group of patients. We report 
on four patients with invasive Fusarium and Mucor 
infection seen in our unit in a five-year period between 
1996 and 2001 to illustrate the changing epidemiology of 
fungal infection in the immunocompromised host. 
Case reports: The first patient was an 8-year old girl with 
acute myeloid leukaemia who developed pyoderma 
gangrenosum-like skin lesions before succumbing to 
disseminated Fusarium infection and acute respiratory 
distress syndrome. The second patient was a 5-month 
old boy who developed pneumonia associated with a 
transient erythematous rash while on chemotherapy for 
congenital leukemia. Blood cultures grew Fusarium 
solani and he was treated successfully with 6 weeks of 
amphotericin B and granulocyte-macrophage colony 
stimulating factor. He died of the underlying malig- 
nancy six months later. The third patient was a 6-year 
old girl who developed a left facial and infraorbital 
cellulitis 6 months after completion of chemotherapy 
for acute lymphoblastic leukaemia. This infection led to 
erosion of her ethmoid and maxillary sinuses, nasal 
septum and palate. Mucor sp. was isolated from a 
maxillary sinus biopsy. She was treated with 60 days of 
amphotericin B and underwent two surgical debride- 
ments before achieving clinical and microbiological 
control. However while on weaning doses of ampho- 
tericin, she had a relapse of her leukaemia and 
recrudescence of Mucor infection. This led to a fatal 
extension to the brain.The fourth patient was a 9-month 
old boy who was having an unrelated cord blood 
transplant in his second clinical remission from infantile 
leukaemia. At day 34 post transplant he developed an 
Aspergillus tunnel infection of his Hickman catheter. 
This infection cleared with catheter removal, surgical 
drainage and amphotericin. On day 81 post transplant 
he developed left hypertonia and facial nerve palsy and 
a space-occupying lesion in the right basal ganglia was 
noted on radioimaging. This was rapidly fatal and 
Fusarium sp. was isolated from a post-mortem brain 
biopsy. 
Conclusions: Progress in the management of childhood 
cancer should be accompanied by improvement in 
therapy for infection. Rapid, accurate diagnosis of 
previously unrecognised pathogens and development of 
increased-spectrum anti-fungal agents are necessary to 
deal with these new, and often fatal, fungal infections. 
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Cryptococcal CNS infections are rare in Norway. Only 
14 cases have been reported to The Norwegian Surveil- 
lance System for Communicable Diseases since 1987. 
Reporting of this infection has been mandatory in Norway 
in this period. 
We describe a patient with Hodgkins lymphoma who 
presented with cryptococcal meningoencephalitis. The 
patient responded to antifungal therapy but later died 
of his lymphoma. 
We also give a short presentation of the other 13 
reported cases comprising both AIDS patients and solid 
organ transplanted patients. 
Although cryptococcal CNS infections are rare, it is 
important to consider the diagnosis in patients with 
lymphoma and AIDS as well as in solid organ trans- 
planted patients, who present with new onset neuro- 
logical symptoms, since this is a treatable disease. 
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Objective: Prophylaxis with fluorquinolones (PFQ) was 
introduced at our center during nineties for prevention 
of bacterial fever and sepsis in high-risk patients: 
i.e., patients who underwent hematopoietic stem cell 
transplantation (HSCT) or high-dose chemotherapy 
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for relapse. Our aim was to compare the incidence of 
resistance to 2nd generation FQ, such as ofloxacin, 
pefloxacin and ciprofloxacin, in bacteria isolated from 
blood cultures of patients who received (group 1) and in 
those who not received PQF (group 2) during the period 
1996-2000. 
Results: Group 1 consisted of 102 febrile episodes in 76 
pts. with a median age of 7.9 years. 72.5% of episodes 
were in HSCT pts. and 23.5 % in relapsed pts. They were 
classified as MID in 24%, as CID in 13 % and as FUO in 
63% of cases. Septic shock was present in 5/102 episodes 
(5%). Early mortality (within 30 days) was observed in 
3/76 pts (4%). The strains isolated from blood were 19 
(13 G+, 5 G-, 1 fungus) and 13 were tested for FQ 
susceptibility: resistance to FQ was observed in 3/S 
G+(37%) and 3/5 G- (60%) , respectively. 
Group 2 consisted of 916 febrile episodes in 341 pts 
with a median age of 5.2 years. Only a minority of 
episodes were in HSCT pts (5%) or in relapsed pts 
(18%). They were classified as MID in 25%, as CID in 
11% and as FUO in 64% of cases. Septic shock was 
present in 23/916 episodes (2.5%). Early mortality was 
observed in 51/341 (15%) pts. The strains isolated from 
blood were 186 (105 G+, 63 G- and 18 fungi) and 156 
were tested for FQ susceptibility: resistance to FQ 
was found in 22/95 G+ (23%) and 4/61 G- (6.5%), 
respectively. 
Conclusions: this data show a major incidence of 
sistemic infections by G- FQ resistent strain in patients 
who were on PFQ although that has not been translated 
in a major incidence of clinically or microbiologically 
demonstrated infections or in a major mortality rate. G+ 
strains appeared intrinsically more resistent to FQ 
because a high rate of resistence was found also in pts 
who were not receiving PFQ. Prospective randomized 
studies are needed to define the role of PFQ prophylaxis 
in reducing severe infections and early mortality in high- 
risk patients. 
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Introduction: The differences in antifungal susceptibility 
of C. glabrata associated with bloodstream invasion, 
infection, and colonization are uncertain. Most systemic 
candidiasis arises from host’s endogenous flora so it is 
important to evaluate the prevalence of drug resistance 
among organisms comprising yeast reservoir to deter- 
mine appropriate prophylactic, preemptive, and empiric 
therapy, especially in high-risk settings. 
Methods: Evaluation of all clinical yeast isolates during 
1998 to 1999 from three large teaching hospitals in New 
York City was performed prospectively. Candida spp. re- 
identification (under code) and susceptibility according 
to NCCLS guidelines was performed at The State 
Department of Health, Albany, New York. 
Results: The level of resistance for fluconazole (FLU) 
and itraconazole (ITRA) among 347 C. glabrata isolates 
was 10.7% and 18.2% respectively. In 33 bloodstream, 
and 314 isolates from other body sites, MICKI for FLU 
was 32.0 Kg/ml and ITRA 1.0 kg/ml. A significant 
difference was observed between isolates from medical 
centers caring for substantial population of patients with 
cancer (Center-I), and AIDS (Center-III) (MI&I for 
FLU 32.0 and >64.0 pg/ml, respectively) and C. glabrata 
isolated from patients at a community-based university 
hospital (Center-II) (MI& for FLU 16.0 kg/ml; 
P=O.OOl). A similar difference for ITRA was not 
significant (P= >0.5). A higher frequency of resistance 
was also noticed among respiratory and urinary tract 
isolates (FLU MI& 264.0 pg/ml). In contract, 46 
isolates obtained from gastrointestinal tract MI&o for 
FLU was ~8.0 kg/ml (P= 0.01). 
Conclusions: The results of present study indicate that 
triazole-derived antifungal susceptibility may not 
significantly differ among C. glabrata associated with 
hematogenous invasion, systemic infection, and colon- 
ization. 
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Introduction: Systemic scedosporiasis due to the 
anamorph/ asexual state of Pseudallescheria boydii has 
emerged as an important cause of opportunistic invasive 
mycosis in the severely immunosuppressed individuals. 
Case report: A 34-year-old man presented with fever 
and hemoptysis, while on oral itraconazole prophylaxis 
8 months after second allogeneic marrow transplant- 
ation for relapsed Philadelphia chromosome positive 
chronic myelogenous leukemia. His WBC was 1400 
